The Good Clinical Trials Collaborative was set up to support excellence in clinical research, globally.
We are developing new guidelines to support a more effective regulatory environment for randomised clinical trials – enabling researchers to efficiently conduct the trials that are needed to improve patient care.
The survey will inform the development of these guidelines by allowing us to gather insights into the impact of the COVID-19 pandemic on clinical trials – both those testing interventions for COVID-19 and trials in other therapeutic areas. We want to capture the innovative practices that have enabled some trials to continue and the barriers and challenges that have impacted others.
We are looking to hear from commercial and academic triallists who have been involved in a clinical trial since January 2020.
This could be in any role type (e.g. investigator, clinical research associate, data analyst), and covers any type of intervention (e.g. vaccine, public health intervention, diagnostic tool).
The survey will be open for 6 weeks, closing at 5:00pm (BST) on Monday 20 July 2020.
It should take no longer than 15 minutes to complete.
The link to the survey is here.
For further information, you can visit our webpage or email us at firstname.lastname@example.org